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Impact of bedside percutaneous dilational and
open surgical tracheostomy on intracranial
pressure, pulmonary gas exchange, and
hemodynamics in neurocritical care patients
Martin Kieninger, MDa,
∗
, Martin Windorfer, MDa, Christoph Eissnert, MDa, Nina Zech, MDa, Sylvia Bele, MDb,
Florian Zemanc, Elisabeth Bründl, MDb, Bernhard Graf, MD, PhDa, Holger Künzig, MDa
Abstract
Aim was to compare the impact of bedside percutaneous dilational tracheostomy (PDT) and open surgical technique (ST) on
intracranial pressure (ICP), pulmonary gas exchange and hemodynamics.
We retrospectively analyzed data of 92 neurocritical care patients with invasive ICPmonitoring during either PDT (43 patients) or ST
(49 patients).
Peak ICP levels were higher during PDT (22 [17–38] mm Hg vs 19 [13–27] mm Hg, P= .029). Mean oxygen saturation (SpO2) and
end-tidal carbon dioxide partial pressure (etCO2) did not differ. Episodes with relevant desaturation (SpO2<90%) or hypercapnia
(etCO2>50mm Hg) occurred rarely (5/49 during ST vs 3/43 during PDT for SpO2<90%; 2/49 during ST vs 5/43 during PDT for
hypercapnia). Drops in mean arterial pressure (MAP) below 60mm Hg were seen more often during PDT (8/43 vs 2/49, P= .026).
Mean infusion rate of norepinephrine did not differ (0.52mg/h during ST vs 0.45mg/h during PDT). No fatal complications were
observed.
Tracheostomy can be performed as ST and PDT safely in neurocritical care patients. The impact on ICP, pulmonary gas exchange
and hemodynamics remains within an unproblematic range.
Abbreviations: CBR = Ciaglia Blue Rhino tracheostomy, ENT specialist = Ear, nose and throat specialist, etCO2 = end-tidal
carbon dioxide partial pressure, FiO2 = fraction of inspired oxygen, HR = heart rate, ICH = intracerebral hemorrhage, ICP =
intracranial pressure, ICU = intensive care unit, IQR = interquartile range, MAP = mean arterial pressure, PDMS = patient data
management system, PDT = percutaneous dilational tracheostomy, PEEP = positive end-expiratory pressure, SAH = subarachnoid
hemorrhage, SBP= systolic blood pressure, SD= standard deviation, SpO2= oxygen saturation, ST= surgical tracheostomy, TBI=
traumatic brain injury, TLT = Fantoni translaryngeal tracheostomy.
Keywords: critical care, hemodynamics, intracranial pressure, pulmonary gas exchange, tracheostomy
1. Introduction
In neurocritical care patients prolonged weaning periods are
often observed and extubation attempts are regularly impeded by
impaired consciousness and insufﬁcient protective reﬂexes. In
those patients, classical weaning criteria are often not reliable in
predicting successful extubation.[1] Extubation failure can
inﬂuence clinical and functional outcome in patients with
traumatic brain injury (TBI)[2] and is independently predicted
by prior neurosurgical treatment in intubated stroke patients.[1]
Hence, tracheostomy is often required in these patients to
improve secretion clearance and it provides a good option for
step by step respirator weaning without need for recurrent
analgosedation and reintubation. Early tracheostomy seems
to be beneﬁcial in patients with severe TBI and neurocritically
ill patients compared to prolonged endotracheal intubation.[3–7]
In general, however, the evidence regarding the best time
for performing tracheostomy in critically ill patients is still
weak.[8–10]
Bedside percutaneous dilational tracheostomy (PDT) has
become a widespread method on most intensive care units
(ICU) during the last two decades. PDT can be regularly
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performed faster than open surgical tracheostomy (ST) and seems
also to be a safe procedure in patients with the most common
neurosurgical diseases.[11] Open ST is usually preferred in
patients with proven difﬁcult airway or coincident necessity
for immobilization of the cervical spine. However, there is little
evidence about the best technique for performing tracheostomy in
critically ill neurosurgical patients.
To address this question, we compared an open surgical
approach to two different techniques of percutaneous dilational
tracheostomy with special regard on intracranial pressure (ICP)
development, pulmonary gas exchange, and hemodynamics
during the procedure.
2. Materials and methods
The study was approved by the Ethics Committee of the
University of Regensburg (approval number 18-1179-104).
Criteria for being included into this study were age above 18
years, presence of a severe brain injury such as TBI, subarachnoid
hemorrhage (SAH), intracerebral hemorrhage (ICH) or severe
cerebral infection with the need for continuous ICP monitoring
and prolonged mechanical ventilation resulting in tracheostomy
which had to be performed bedside on the ICU. Accordingly,
exclusion criteria were an age below 18 years, pregnancy and a
lacking ICP monitoring.
The database of the patient data management system (PDMS,
MetaVision SuiteTM, iMDsoft, Tel Aviv, Israel) on the neurosur-
gical ICU and a mixed surgical ICU at the University Hospital
Regensburg was screened retrospectively between 2003 and 2014
for the key words “presence of a tracheostoma” and “presence of
an ICP-measurement”. Patients who met both queries were
screened for inclusion and exclusion criteria and the data sets
were checked for integrity. If all selectional criteria could be
fulﬁlled, the patient was enrolled into the study (see Flow Chart,
Supplemental Digital Content, which illustrates study selection,
http://links.lww.com/MD/D208).
Tracheostomy was performed either by a surgical (surgical
tracheostomy, ST) or a percutaneous dilational technique
(percutaneous dilational tracheostomy, PDT). All open surgeries
were performed by an ear, nose, and throat (ENT) specialist. For
dilational tracheostomy, two different techniques were used
depending by whom the tracheostomy was carried out. For
dilational tracheostomies performed by an ENT specialist the
technique described by Fantoni (Fantoni translaryngeal trache-
ostomy, TLT,[12]) was used. Tracheostomies conducted by the
team of the ICU without support of the ENT department were
performed using the Ciaglia Blue Rhino (CBR) technique.[13]
The decision for tracheostomy and the choice of the
appropriate technique were made by the attending ICU
physicians according to each patient’s constitution and estimated
time of required respiratory therapy. A speciﬁc weaning protocol
did not exist.
For every included patient parameters regarding ventilation
and pulmonary gas exchange (fraction of inspired oxygen, FiO2;
oxygen saturation, SpO2; end-tidal carbon dioxide partial
pressure, etCO2; positive end-expiratory pressure, PEEP),
hemodynamic situation (heart rate, HR; mean arterial pressure,
MAP; systolic blood pressure, SBP), use of vasopressors (infusion
rate of norepinephrine) and the dosage of narcotics and opioids
(infusion rate and bolus injection of propofol, midazolam,
ketamine and sufentanil) as well as the course of ICP including
interventions for lowering an elevated ICP were extracted from
the PDMS within a period from 24hours before until 24hours
after tracheostomy. In addition, peri- and post-procedural
complications, as well as infections probably associated with
tracheostomy were recorded (see Table, Supplemental Digital
Content, which provides all raw data recorded for the study,
http://links.lww.com/MD/D208).
Tracheostomy was performed under intravenous anesthesia in
all cases with additional local anesthesia given on top in almost
all cases.
Statistical analysis was performed using IBM SPSS StatisticsTM
25 (IBM, Armonk, NY). Categorical data were presented as
absolute and relative frequencies and were compared between ST
and PDT using a Chi-square-test of independence. Continuous
data were presented as mean ± SD or as median [interquartile
range (IQR)] depending on the underlying distribution. Study
groups were compared using Student’s t test for normal
distributed andMann-WhitneyU test for non-normal distributed
data. Level of signiﬁcance was set to P< .05. In this retrospective,
exploratory study, no a priori sample size calculation was
performed. Instead, all available patients in a pre-deﬁned period
were included to maximize the power.
3. Results
After eliminating all patients whose data sets were incomplete or
who had any kind of exclusion criteria, 92 patients (27 female, 65
male) could be enrolled in the present study. ST was performed in
49 cases and PDT in 43 cases (39 TLT, 4 CBR), respectively. The
underlying cerebral disorders of the included patients are listed in
Table 1.
The number of failed extubation attempts preceding tracheos-
tomy did not differ signiﬁcantly between both groups (four
patients, 8.2% in PDT group vs six patients, 14.0% in ST group,
P= .373). Tracheostomy was performed earlier in the ST group
(day 10 [8–14] after admission to ICU vs day 14 [11–18] in PDT
group, P< .001). There was no statistically signiﬁcant difference
in the required total days with mechanical ventilation on ICU
(25.7±9.4 day in ST group vs 27.7±11.5 days in PDT group,
P= .373) and remaining days after tracheostomy with demand
for respiratory therapy (15.3±7.7 days in ST group vs 14.0±8.3
days in PDT group, P= .454). Length of ICU stay did not differ
between both groups (28±10 days in ST group vs 32±12 days in
PDT group, P= .090). Procedure time for PDT was signiﬁcantly
shorter (50 [40–60] minutes for ST vs 30 [25–40] minutes for
PDT, P< .001).
The course of ICP values from 24hours before until 24hours
after tracheostomy is shown in Table 2. Mean ICP values did not
differ during the whole periprocedural period except at 2 hours
Table 1
Cerebral disorder of included patients.
ST PDT P value
Number of patients 49 43
Cerebral disorder
TBI 22 (44.9%) 17 (39.5%) .608
ICH 12 (24.5%) 7 (16.2%) .332
SAH 12 (24.5%) 15 (34.9%) .283
Cerebral infarction 2 (4.1%) 2 (4.7%) .896
Cerebral infection 1 (2.0%) 2 (4.7%) .499
ST= surgical tracheostomy, PDT=percutaneous dilational tracheostomy, TBI= traumatic brain injury,
ICH= intracerebral hemorrhage, SAH= subarachnoid hemorrhage.
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after tracheostomy when the mean ICP value was higher in the ST
group (11.0±5.2minutes vs 8.8±4.0minutes, P= .029). On the
other hand, the median peak ICP level during tracheostomy was
higher in the PDT group than in the ST group (22 [17–38] mmHg
vs 19 [13–27] mmHg, P= .029). During tracheostomy procedure
at least 1 measured ICP value above 20mmHg was recognized in
28 patients of the PDT group and in 23 patients of the ST group,
respectively (65.1% vs 46.9%, P= .080).
Medical treatment for ICP control during tracheostomy was
necessary in seven patients of the ST group (17.3%) and in 12
patients of the PDT group (27.9%, P= .107). The frequency of
speciﬁc measures is listed in Table 3.
Respiratory and ventilation parameters are listed in Table 4.
FiO2 values were signiﬁcantly lower in the PDT group 24 and two
hours before and 24hours after tracheostomy. Accordingly, the
mean PEEP was lower in the PDT group 24 and two hours before
and 2 and 24hours after tracheostomy. SpO2 and etCO2 did not
differ between both groups in the time period 24hours before
until 24hours after tracheostomy. The number of patients with at
least 1 measured drop of SpO2 below 90% during tracheostomy
did not differ between both groups (5 patients, 10.2% in ST
group vs 3 patients, 7.0% in PDT group, P= .584). At least 1
episode with an elevation of etCO2 above 50mm Hg during
tracheostomy was observed in 2 patients (4.1%) in ST group vs 5
patients (11.6%) in PDT group, not reaching statistical
signiﬁcance (P= .173).
Regarding hemodynamic parameters, we focused on HR and
MAP throughout the procedure (Table 5). None of the patients‘
HR fell below 45/min, the highest HR measured was 134/min in
the ST group and 117/min in the PDT group, respectively. During
tracheostomy neither mean HR nor mean MAP differed
signiﬁcantly between both groups (79/min±15/min in ST group
vs 85/min±14/min in PDT group, P= .070; 93±11mmHg in ST
group vs 94±12mmHg in PDT group, P= .632). The cumulative
time with aMAP lower than 60mmHg during tracheostomy was
less than 1 minute in both groups. Hemodynamic support with
norepinephrine during tracheostomy was required in 42 patients
in the ST group and 34 patients in the PDT group (85.7% vs
79.1%, P= .402). The infusion rate of norepinephrine during
tracheostomy did not differ between both groups (0.4 [0.1–0.7]
mg/h in ST group vs 0.3 [0.1–0.6] mg/h in PDT group, P= .496).
The number of patients with at least 1 episode of a drop of the
MAP below 60mm Hg was higher in the PDT group (8 patients,
18.6% in PDT group vs 2 patients, 4.1% in PDT group,
P= .026).
Table 2
Course of intracranial pressure (ICP) during tracheostomy (TS) and
periprocedural. Data are presented as mean ± standard deviation
(SD) when normally distributed, and as median [interquartile range
(IQR)] when non-normally distributed.
ST (n=49) PDT (n=43) P value
ICP 24 h before TS (mm Hg) 10.4±4.2 10.6±3.6 .817
ICP 2 h before TS (mm Hg) 11.5±5.2 10.7±4.2 .764
Time with ICP>20 mmHg in
the period 24 h before TS (min)
12 [0–57] 9 [0–45] .959
ICP during TS (mm Hg) 15.6±5.5 15.4±6.7 .887
Highest ICP level during TS (mm Hg) 19 [13–27] 22 [17–38] .029
Time with ICP>20 mmHg during
TS (min)
0 [0–15] 3 [0–10] .927
ICP 2 h after TS (mm Hg) 11.0±5.2 8.8±4.0 .029
ICP 24 h after TS (mm Hg) 10.9±4.7 10.6±3.6 .688
Time with ICP>20 mmHg in the
period 24 h after TS (min)
13 [1–95] 6 [0–36] .178
Table 3
Number of patients requiring medication for lowering an elevated
intracranial pressure (ICP) during tracheostomy (TS).
ST (n=49) PDT (n=43) P value
Thiopental 4 (9.3%) 9 (18.4%) .079
Mannitol 20% 5 (11.6%) 4 (8.2%) .885
Sodium chloride 20% 1 (2.3%) 2 (4.1%) .482
Trometamol 1 (2.3%) 0 .346
Table 4
Respiratory and ventilation parameters during tracheostomy (TS)
and periprocedural. FiO2, fraction of inspired oxygen; PEEP,
positive end-expiratory pressure; SpO2, oxygen saturation; etCO2,
end-tidal carbon dioxide partial pressure. Data are presented as
mean ± standard deviation (SD) when normally distributed, and as
median [interquartile range (IQR)] when non-normally distributed.
ST (n=49) PDT (n=43) P value
FiO2 24 h before TS (%) 40 [36–45] 36 [31–40] .002
FiO2 2 h before TS (%) 42 [37–51] 38 [35–44] .001
FiO2 during TS (%) 100 [100–100] 100 [100–100] .248
FiO2 2 h after TS (%) 44 [40–50] 40 [35–50] .196
FiO2 24 h after TS (%) 41 [38–49] 37 [34–43] .001
PEEP 24 h before TS (mbar) 9.4±2.8 7.4±1.8 <.001
PEEP 2 h before TS (mbar) 9 [7–11] 7 [6–8] <.001
PEEP 2 h after TS (mbar) 9 [7–11] 7 [6–8] <.001
PEEP 24 h after TS (mbar) 9.1±2.7 7.3±1.8 <.001
SpO2 24 h before TS (%) 99 [98–100] 99 [98–100] .325
SpO2 2 h before TS (%) 99 [98–100] 99 [98–100] .354
SpO2 during TS (%) 100 [99–100] 100 [99–100] .944
SpO2 2 h after TS (%) 99 [98–100] 99 [98–100] .435
SpO2 24 h after TS (%) 99 [98–99] 99 [98–100] .246
etCO2 24 h before TS (mmHg) 37.0±5.1 37.7±5.3 .577
etCO2 2 h before TS (mmHg) 36.7±5.5 37.3±6.8 .677
etCO2 during TS (mmHg) 34.7±5.0 35.7±7.0 .508
etCO2 2 h after TS (mmHg) 34.7±5.0 36.1±5.3 .264
etCO2 24 h after TS (mmHg) 36.2±4.7 36.7±5.5 .729
Table 5
Heart rate (HR) and mean arterial pressure (MAP) during
tracheostomy (TS). Data are presented as mean ± standard
deviation (SD) when normally distributed, and as median [inter-
quartile range (IQR)] when non-normally distributed.
ST (n=49) PDT (n=43) P value
HR 1 h before TS (/min) 77±14 83±14 .057
HR during TS (/min) 79±15 85±14 .070
Cumulative time with HR<45/min
during TS (min)
0 [0–0] 0 [0–0] 1.000
Cumulative time with HR>120/min
during TS (min)
0 [0–0] 0.4 [0–0] .064
MAP 1 h before TS (mm Hg) 92±12 92±12 .933
MAP during TS (mm Hg) 93±11 94±12 .632
Cumulative time with MAP<60mm Hg
during TS (min)
0 [0–0] 0 [0–0] .099
Cumulative time with MAP>100mm Hg
during TS (min)
9 [0–20] 6 [2–12] .308
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The required dosages of sedatives and opioids during
tracheostomy were similar in both groups except a
remarkably higher infusion rate for sufentanil in the PDT
group (Table 6).
In 3 cases, relevant complications during ST were documented
in the PDMS. Two times a serious bleeding occurred, in 1 case
difﬁculties during insertion of the tracheal cannula leaded to a
relevant drop of SpO2. In the further course of ICU treatment, in
1 case of ST operative revision was required due to impaired
wound healing. In another case, a serious infection of the
tracheostoma occurred. During PDT reintubation was required
in two cases because the insertion of the tracheal cannula was not
possible. One patient of the PDT group required the replacement
of the tracheal cannula within 24hours after tracheostomy due to
cuff leakage.
CRP values just before tracheostomy did not differ signiﬁcantly
between both groups (112.8±70.7mg/L in ST group vs 94.7±
64.2mg/L in PDT group, P= .212). During the 7 days following
tracheostomy, a relevant increase in CRP value did not occur in
either group. On the day of tracheostomy most of the patients in
both groups required antibiotic therapy (83.7% in ST group vs
70.0% in PDT group, P= .113). After tracheostomy a remark-
ably high percentage of patients in the PDT group required a new
antibiotic therapy or the escalation of the preceding regime
(46.5% in PDT group vs 24.5% in ST group, P= .008).
4. Discussion
In the present study, we compared different tracheostomy
methods (ST and PDT) in critically ill neurosurgical patients
with regard to procedure duration and the course of ICP values
and vital parameters.
The ﬁnding that the median procedure time for ST was 50
minutes vs 30minutes for PDT could be a considerable argument
for preferring PDT in neurointensive care patients as a shorter
surgical time for tracheostomy is assumed to be a crucial factor to
avoid ICP increases during the procedure in the literature.[11]
However, the median duration of 30minutes for PDT in the
present study seems to be considerably longer compared to a
mean duration for PDT of only 13.1minutes reported in a meta-
analysis published in 2014.[14] A possible explanation for this
difference could be divergent deﬁnitions of the start and end point
of the procedure. In addition, the duration of a procedure like
PDT is mainly dependent on experience. At university medical
centers, procedures like tracheostomy are often performed by
young colleagues under supervision of an experienced instructor
understandably leading to a longer duration.
In the present study, ST was performed signiﬁcantly earlier
than PDT (median day 10 after admission to the ICU vs day 14).
A possible explanation could be that ST is preferred in patients
with a difﬁcult airway when PDT is contraindicated. In these
cases, extubation attempts are often estimated to be too
dangerous as reintubation is expected to be challenging leading
to a priori tracheostomy. However, failed tracheostomy-preced-
ing extubation attempts were not observed more often in patients
ﬁnally receiving PDT.
Since neurocritical care patients often show fairly controlled
ICP levels over a longer period of time, external stimuli like
invasive procedures such as PDT or ST may lead to signiﬁcant
increases in ICP. The timing of tracheostomy, however, seems
not to inﬂuence ICP.[15] Patients in both groups of the present
study had well controlled ICP values within the last 24hours
before tracheostomy was performed. Throughout the surgery, a
slight increase in middle ICP levels within both groups was seen
reﬂecting the general impact of the intervention. Remarkably,
peak ICP levels were higher in the PDT group indicating a higher
impact of PDT technique on ICP compared to ST. Regarding the
number of patients with at least 1 episode of a measured ICP
value above 20mm Hg there was a trend towards a higher
frequency in the PDT group, but medicamentous intervention
for lowering ICP was not necessary more often. Data regarding
ICP levels during tracheostomy are rare. Kuechler et al reported
on a temporarily elevated ICP during PDT in 24% of the
cases.[11] In this study, severe hypercapnia occurred only in 15%
suggesting that this seems not to be the only reason for causing
ICP elevation during tracheostomy. Milanchi et al did only
measure a temporary slight and statistically non-signiﬁcant
increase in ICP during PDT and concluded that PDT is safe in
neurosurgical patients.[16] This is in accordance with our data
since we also found an increase in ICP which stayed within
acceptable ranges and the rate of severe hypercapnia during
tracheostomy was low. Kleffmann et al reported on a signiﬁcant
rise of ICP during PDT procedure. The mean ICP values,
however, remained below 20mm Hg.[17] Stocchetti et al
compared ST and PDT regarding the effect on ICP and found
a signiﬁcant increase of ICP regardless of which technique was
performed. Intracranial hypertension with ICP above 20mm
Hg, however, occurred more often in PDT group.[18] Kuechler
et al reported on a temporarily rising ICP during PDT in 24% of
the cases without affecting cerebral perfusion pressure (CPP).
Surgery time and hypercapnia were identiﬁed to be risk factors
for intraoperative ICP elevation.[11]
More patients in the PDT group had at least 1 episode with
MAP falling below 60mm Hg. However, the infusion rate of
norepinephrine did not differ between both groups. Kleffmann
et al reported on rising MAP to mean values above 100mm Hg
during PDT.[17] This, however, should be avoidable when
sufﬁciently deep anesthesia during tracheostomy is ensured.
Episodes with arterial hypotension during PDT in brain-injured
patients occurred in only 3 of 289 cases in the study mentioned
above.[11] This is in line with our ﬁndings where relevant drops in
MAP could be avoided in all cases.
Severe complications rarely occurred in both groups which is
in line with prior ﬁndings in neurological[11] and unselected
ICU patients.[19] The rate of lethal complications is about
0.65% for both techniques.[20] A large meta-analysis compar-
ing ST and percutaneous tracheostomy revealed a higher rate of
Table 6
Mean infusion rate and bolus injection of sedatives and opioids
during tracheostomy (TS). Data are presented as mean±standard
deviation (SD) when normally distributed, and as median [inter-
quartile range (IQR)] when non-normally distributed.
ST
(n=49)
PDT
(n=43) P value
Infusion rate of propofol during TS (mg/h) 200 [60–240] 200 [0–300] .183
Bolus injection of propofol during TS (mg) 0 [0–45] 0 [0–80] .443
Infusion rate of midazolam during TS (mg/h) 0 [0–14] 0 [0–20] .728
Bolus injection of midazolam during TS (mg) 0 [0–0] 0 [0–0] .626
Infusion rate of ketamine during TS (mg/h) 0 [0–175] 0 [0–150] .524
Bolus injection of ketamine during TS (mg) 0 [0–0] 0 [0–0] .415
Infusion rate of sufentanil during TS (mg/h) 80 [33–100] 40 [0–80] .013
Bolus injection of sufentanil during TS (mg) 0 [0–40] 0 [0–30] .931
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wound infection after ST in unselected critically ill adult
patients.[14] In an older meta-analysis a trend toward fewer
complications in percutaneous techniques was reported.[21]
Delaney et al found a lower incidence of wound infection and
reduced clinical relevant bleeding when PDT is performed
compared to ST.[22]
The main limitation of our study is its retrospective design.
Retrospective database researches are often limited due to data
quality. In addition, continuous measurement of ICP during
tracheostomy was required for being included in the present
study. Obviously, in many cases the probe for measuring ICP
had been removed prior to performance of tracheostomy
leading to a relatively small sample size. In addition, the fact
that FiO2 and PEEP were lower in the PDT group 24 and 2
hours before and 24hours after tracheostomy indicates that ST
was preferably performed in patients with pulmonary problems
due to safety reasons. This could have led to a certain bias with
patients with a poorer condition being overrepresented in the
ST group. Finally, it has to be clariﬁed that the decision for
tracheostomy was not based on a weaning protocol but was
according to the estimation of the attending ICU physicians in
the particular case.
In summary, we can conclude that tracheostomy in critically
ill neurointensive care patients is safe irrespective of which
technique is used. During tracheostomy increased ICP levels are
observed but remain within acceptable ranges. PDT seems to
have a higher impact on ICP than ST although PDT can be
performed faster than ST. A problematic drop in SpO2,
severe hypercapnia and arterial hypotension during tracheos-
tomy rarely occur irrespectively of the tracheostomy
technique used.
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